Sandwich enzyme-immunoassay for dipeptidyl aminopeptidase IV in the serum of people with oral cancer.
A highly-sensitive sandwich enzyme immunoassay for serum dipeptidyl aminopeptidase IV (DAP IV) was developed; its level in sera of patients with oral cancer [1.50 +/- 0.35(SD)mg/l serum] was significantly lower than in normal subjects [2.27 +/- 0.77(SD)mg/l serum].